Literature DB >> 22058062

Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors.

Nadia Ben Fredj1, Antonella Rotola, Faten Nefzi, Saber Chebel, Roberta Rizzo, Elisabetta Caselli, Mahbouba Frih-Ayed, Dario Di Luca, Mahjoub Aouni.   

Abstract

Members of the human Herpesviridae family are candidates for representing the macroenvironmental factors associated with multiple sclerosis (MS) pathogenesis. To verify the possible role of human herpesviruses (HHVs) as triggering or aggravating factors in relapsing-remitting multiple sclerosis clinical outcome, we studied the prevalence of all eight human herpesviruses in whole blood samples collected from 51 MS patients and from 51 healthy controls. The presence of DNA of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), varicella zoster virus (VZV), Epstein-Barr virus (EBV), human cytomegalovirus (HCMV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7) and human herpesvirus 8 (HHV-8) was searched by specific nested polymerase chain reaction. HHVs were significantly more prevalent in the blood of MS patients than in those of the controls (P < 10(-4)). HSV-1, HSV-2, HCMV and HHV-8 were negative in both MS patients and controls samples. In MS patients, EBV, HHV-7, HHV-6 and VZV were detected in 31.3%, 33.3%, 5.8% and 7.8% of samples, respectively, compared with 3.9%, 9.8%, 1.96% and 1.96%, respectively, of samples from controls. We found a statistically significant difference only for EBV DNA and for HHV-7 DNA prevalence (P < 0.001 and P = 0.03). Although these results indicate lack of apparent association in terms of gender, type of diagnosis, symptoms, disease score and β interferon treatment between EBV or HHV-7 to MS among Tunisian patients, heterogeneity related to genetic polymorphism as well as geographical distribution of the disease and of pathogens may be of significance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22058062     DOI: 10.1007/s13365-011-0056-z

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  39 in total

1.  Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA.

Authors:  Alfonso Martínez; Roberto Alvarez-Lafuente; Ana Mas; Manuel Bartolomé; Marta García-Montojo; Virginia de Las Heras; Emilio G de la Concha; Rafael Arroyo; Elena Urcelay
Journal:  Hum Immunol       Date:  2007-06-21       Impact factor: 2.850

Review 2.  Infectious causes of multiple sclerosis.

Authors:  Gavin Giovannoni; Gary R Cutter; Jan Lunemann; Roland Martin; Christian Münz; Subramaniam Sriram; Israel Steiner; Margaret R Hammerschlag; Charlotte A Gaydos
Journal:  Lancet Neurol       Date:  2006-10       Impact factor: 44.182

3.  Prevalence of herpesvirus DNA in MS patients and healthy blood donors.

Authors:  R Alvarez-Lafuente; C Martín-Estefanía; V de las Heras; C Castrillo; I Cour; J J Picazo; E Varela De Seijas; R Arroyo
Journal:  Acta Neurol Scand       Date:  2002-02       Impact factor: 3.209

4.  Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients.

Authors:  Robert Zivadinov; Davide Nasuelli; Maria Antonietta Tommasi; Maurizia Serafin; Alessio Bratina; Maja Ukmar; Istvan Pirko; Aaron J Johnson; Christina Furlan; Roberto S Pozzi-Mucelli; Luisa Monti-Bragadin; Attilio Grop; Massimo Zambon; Rodolfo M Antonello; Giuseppe Cazzato; Marino Zorzon
Journal:  Neurol Res       Date:  2006-04       Impact factor: 2.448

5.  Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis.

Authors:  C Taus; E Pucci; E Cartechini; A Fié; G Giuliani; M Clementi; S Menzo
Journal:  Acta Neurol Scand       Date:  2000-04       Impact factor: 3.209

6.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

7.  Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study.

Authors:  Jiunn-Horng Kang; Jau-Jiuan Sheu; Senyeong Kao; Herng-Ching Lin
Journal:  J Infect Dis       Date:  2011-06-07       Impact factor: 5.226

8.  High susceptibility of a human oligodendroglial cell line to herpes simplex type 1 infection.

Authors:  Raquel Bello-Morales; María Fedetz; Antonio Alcina; Enrique Tabarés; José Antonio López-Guerrero
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

9.  Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients.

Authors:  S S Soldan; T P Leist; K N Juhng; H F McFarland; S Jacobson
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

10.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

View more
  7 in total

1.  Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.

Authors:  Nadia Ben-Fredj; Walid Ben-Selma; Antonella Rotola; Faten Nefzi; Sabrina Benedetti; Mahbouba Frih-Ayed; Dario Di Luca; Mahjoub Aouni; Elisabetta Caselli
Journal:  J Neurovirol       Date:  2012-11-21       Impact factor: 2.643

Review 2.  Infectious agents and neurodegeneration.

Authors:  Giovanna De Chiara; Maria Elena Marcocci; Rossella Sgarbanti; Livia Civitelli; Cristian Ripoli; Roberto Piacentini; Enrico Garaci; Claudio Grassi; Anna Teresa Palamara
Journal:  Mol Neurobiol       Date:  2012-08-17       Impact factor: 5.590

3.  Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.

Authors:  Nourollah Ramroodi; Nima Sanadgol; Zohre Ganjali; Abbas Ali Niazi; Vida Sarabandi; Ali Moghtaderi
Journal:  J Pathog       Date:  2013-01-22

Review 4.  Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.

Authors:  Michael P Pender; Scott R Burrows
Journal:  Clin Transl Immunology       Date:  2014-10-31

5.  Varicella zoster virus-associated morbidity and mortality in Africa - a systematic review.

Authors:  Hannah Hussey; Leila Abdullahi; Jamie Collins; Rudzani Muloiwa; Gregory Hussey; Benjamin Kagina
Journal:  BMC Infect Dis       Date:  2017-11-14       Impact factor: 3.090

6.  HLA alleles modulate EBV viral load in multiple sclerosis.

Authors:  Simone Agostini; Roberta Mancuso; Franca R Guerini; Sandra D'Alfonso; Cristina Agliardi; Ambra Hernis; Milena Zanzottera; Nadia Barizzone; Maurizio A Leone; Domenico Caputo; Marco Rovaris; Mario Clerici
Journal:  J Transl Med       Date:  2018-03-27       Impact factor: 5.531

7.  Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS).

Authors:  Nourollah Ramroodi; Abbas Ali Niazi; Nima Sanadgol; Zohre Ganjali; Vida Sarabandi
Journal:  Braz J Infect Dis       Date:  2013-03-05       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.